On November 27, Gelonghui (300937.SZ) announced that it recently received the “Notice Letter on Reducing the Shares of Sichuan Hezong Pharmaceutical Co., Ltd. by a total of 1% and the progress of the reduction” issued by Mr. Tian Wenshu, a shareholder holding at least 5% of the company's shares and supervisor. It was learned that Mr. Tian Wenwen reduced his holdings of the company's shares by a total of 1,203,095 shares through centralized bidding between July 19, 2023 and November 24, 2023. The reduction in shareholding accounts for 1.26% of the company's total share capital.
药易购(300937.SZ):田文书累计减持1.26%股份
Pharmaceutical Easy Purchase (300937.SZ): Tianwen reduced its shares by 1.26% by a total of 1.26%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.